Is α7-nAChR a Possible Target for Lung Cancer and Malignant Pleural Mesothelioma Treatment?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|13|5|688-694

ISSN： 1389-4501

Source： Current Drug Targets, Vol.13, Iss.5, 2012-05, pp. : 688-694

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulatory Role of the α7nAChR in Cancer

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 680-687

Bentham Science Publishers

Access to resources Recommend Favorite

A New “Era” for the α7-nAChR

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 721-725

Bentham Science Publishers

Access to resources Recommend Favorite

Concluding Notes of Special Issue “α-7 Nicotinic Receptor (α7-nAChR): One Target Different Diseases”

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 726-727

Bentham Science Publishers

Access to resources Recommend Favorite

α7 nAChR in Airway Respiratory Epithelial Cells

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 666-670

Bentham Science Publishers

Access to resources Recommend Favorite

The Recent Development of 7 Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2134-2151

Bentham Science Publishers

Access to resources Recommend Favorite